Registries for Rare Diseases

A foundation for multi-arm, multi-company trials

White Paper

January 15, 2019
Registries for Rare Diseases
This white paper examines how registries can provide a valuable foundation for multi-arm, multi-company trials by fostering long-term, collaborative relationships between rare disease stakeholders and improving our understanding of diseases and treatment outcomes.